-
1
-
-
0343867237
-
Novel peroral dosage forms with protease inhibitory activities. I. Design of capsules with fast gel-forming and fast drug-releasing properties
-
Akiyama, Y., Lueßen, H.L., de Boer, A.G., Verhoef, J.C. and Junginger, H.E., Novel peroral dosage forms with protease inhibitory activities. I. Design of capsules with fast gel-forming and fast drug-releasing properties. Int. J. Pharm., 136 (1996a) 155-163.
-
(1996)
Int. J. Pharm.
, vol.136
, pp. 155-163
-
-
Akiyama, Y.1
Lueßen, H.L.2
De Boer, A.G.3
Verhoef, J.C.4
Junginger, H.E.5
-
2
-
-
0030581138
-
Novel peroral dosage forms with protease inhibitory activities. II. Design of fast dissolving poly(acrylate) and controlled drug-releasing capsule formulations with trypsin inhibiting properties
-
in press
-
Akiyama, Y., Lueßen, H.L., de Boer, A.G., Verhoef, J.C. and Junginger, H.E., Novel peroral dosage forms with protease inhibitory activities. II. Design of fast dissolving poly(acrylate) and controlled drug-releasing capsule formulations with trypsin inhibiting properties. Int. J. Pharm., (1996a) in press.
-
(1996)
Int. J. Pharm.
-
-
Akiyama, Y.1
Lueßen, H.L.2
De Boer, A.G.3
Verhoef, J.C.4
Junginger, H.E.5
-
3
-
-
0014525152
-
Pyrrolidonecarboxyl peptidase: Stabilization and purification
-
Armentrout, R.W. and Doolittle, R.F., Pyrrolidonecarboxyl peptidase: stabilization and purification. Arch. Biochem. Biophys., 132 (1969) 80-90.
-
(1969)
Arch. Biochem. Biophys.
, vol.132
, pp. 80-90
-
-
Armentrout, R.W.1
Doolittle, R.F.2
-
4
-
-
0019871624
-
A high yield preparation for rat kidney brush border membranes - different behaviour of lysosomal markers
-
Biber, J., Stieger, B., Haase, W. and Murer, H., A high yield preparation for rat kidney brush border membranes - different behaviour of lysosomal markers. Biochim. Biophys. Acta, 647 (1981) 169-176.
-
(1981)
Biochim. Biophys. Acta
, vol.647
, pp. 169-176
-
-
Biber, J.1
Stieger, B.2
Haase, W.3
Murer, H.4
-
5
-
-
0026555037
-
Proteases and proteolysis in the lysosome
-
Bohley, P. and Seglen, P.O., Proteases and proteolysis in the lysosome. Experientia, 48 (1992) 151-157.
-
(1992)
Experientia
, vol.48
, pp. 151-157
-
-
Bohley, P.1
Seglen, P.O.2
-
7
-
-
0027131431
-
General occurence of binding synergism in zinc proteases and its possible significance
-
Chan, W.W.-C. and Pfuetzner, R.A., General occurence of binding synergism in zinc proteases and its possible significance. Eur. J. Biochem., 218 (1993) 529-534.
-
(1993)
Eur. J. Biochem.
, vol.218
, pp. 529-534
-
-
Chan, W.W.-C.1
Pfuetzner, R.A.2
-
8
-
-
0027729733
-
The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation
-
Cleland, J.L., Powell, M.F. and Shire, S.J., The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Crit. Rev. Therapeutic Drug Carrier Syst., 10 (1993) 307-377.
-
(1993)
Crit. Rev. Therapeutic Drug Carrier Syst.
, vol.10
, pp. 307-377
-
-
Cleland, J.L.1
Powell, M.F.2
Shire, S.J.3
-
9
-
-
0029562489
-
Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects
-
Constantinides, P.P., Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res., 12 (1995) 1561-1572.
-
(1995)
Pharm. Res.
, vol.12
, pp. 1561-1572
-
-
Constantinides, P.P.1
-
10
-
-
0026548881
-
Three-dimensional structure of porcine pancreatic procarboxypeptidase A - a comparison of the A and B zymogens and their determinants for inhibition and activation
-
Guasch, A., Coll, M., Avilés, F.X. and Huber, R., Three-dimensional structure of porcine pancreatic procarboxypeptidase A - a comparison of the A and B zymogens and their determinants for inhibition and activation. J. Mol. Biol., 224 (1992) 141-157.
-
(1992)
J. Mol. Biol.
, vol.224
, pp. 141-157
-
-
Guasch, A.1
Coll, M.2
Avilés, F.X.3
Huber, R.4
-
11
-
-
0026584007
-
The early and late processing of lysosomal enzymes: Proteolysis and compartimentation
-
Hasilik, A., The early and late processing of lysosomal enzymes: proteolysis and compartimentation. Experientia, 48 (1992) 130-150.
-
(1992)
Experientia
, vol.48
, pp. 130-150
-
-
Hasilik, A.1
-
12
-
-
43949172738
-
Non-ionic surfactant vesicles: A study of vesicle formation, characterization, and stability
-
Hofland, H.E.J., Bouwstra, J.A., Spies, F., Talsma, H. and Junginger, H.E., Non-ionic surfactant vesicles: a study of vesicle formation, characterization, and stability. J. Colloid Interface Sci., 161 (1993) 366-376. *
-
(1993)
J. Colloid Interface Sci.
, vol.161
, pp. 366-376
-
-
Hofland, H.E.J.1
Bouwstra, J.A.2
Spies, F.3
Talsma, H.4
Junginger, H.E.5
-
13
-
-
0028049233
-
Metabolism and transport of the pentapeptide by brush-border membrane vesicles of rat intestine
-
Langguth, P., Bohner, V., Biber, J. and Merkle, H.P., Metabolism and transport of the pentapeptide by brush-border membrane vesicles of rat intestine. J. Pharm. Pharmacol., 46 (1994a) 34-40.
-
(1994)
J. Pharm. Pharmacol.
, vol.46
, pp. 34-40
-
-
Langguth, P.1
Bohner, V.2
Biber, J.3
Merkle, H.P.4
-
14
-
-
0028215218
-
Oral absorption of peptides: The effect of absorption site and enzyme inhibition on the systemic availability of metkephamid
-
Langguth, P., Merkle, H.P. and Amidon, G.L., Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid. Pharm. Res., 11 (1994b) 528-535.
-
(1994)
Pharm. Res.
, vol.11
, pp. 528-535
-
-
Langguth, P.1
Merkle, H.P.2
Amidon, G.L.3
-
15
-
-
0000888476
-
Enzymatic barriers to peptide and protein drug delivery
-
Lee, V.H.L. (Ed.), Marcel Dekker, New York
-
Lee, V.H.L., Traver, R.D. and Taub, M.E., Enzymatic barriers to peptide and protein drug delivery. In Lee, V.H.L. (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, New York, 1991, pp. 303-358.
-
(1991)
Peptide and Protein Drug Delivery
, pp. 303-358
-
-
Lee, V.H.L.1
Traver, R.D.2
Taub, M.E.3
-
16
-
-
0028283741
-
Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: Protection against proteases and effect on intestinal absorption in rats
-
Lowe, P.J. and Temple, C.S., Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J. Pharm. Pharmacol., 46 (1994) 547-552.
-
(1994)
J. Pharm. Pharmacol.
, vol.46
, pp. 547-552
-
-
Lowe, P.J.1
Temple, C.S.2
-
17
-
-
71849104860
-
Protein measurement with the folin phenol reagent
-
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the folin phenol reagent. J. Biol. Chem., 193 (1951) 265-275.
-
(1951)
J. Biol. Chem.
, vol.193
, pp. 265-275
-
-
Lowry, O.H.1
Rosebrough, N.J.2
Farr, A.L.3
Randall, R.J.4
-
18
-
-
0028788346
-
Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin
-
Lueßen, H.L., Borchard, G., Verhoef, J.C., Lehr, C.-M., de Boer, A.G. and Junginger, H.E., Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm. Res., 12 (1995) 1293-1298.
-
(1995)
Pharm. Res.
, vol.12
, pp. 1293-1298
-
-
Lueßen, H.L.1
Borchard, G.2
Verhoef, J.C.3
Lehr, C.-M.4
De Boer, A.G.5
Junginger, H.E.6
-
19
-
-
17344382638
-
Mucoadhesive excipients in peroral peptide drug delivery. I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes
-
Lueßen, H.L., de Leeuw, B.J., Pérard, D., Lehr, C.-M., de Boer, A.G., Verhoef, J.C. and Junginger, H.E., Mucoadhesive excipients in peroral peptide drug delivery. I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes. Eur. J. Pharm. Sci., 4 (1996) 117-128.
-
(1996)
Eur. J. Pharm. Sci.
, vol.4
, pp. 117-128
-
-
Lueßen, H.L.1
De Leeuw, B.J.2
Pérard, D.3
Lehr, C.-M.4
De Boer, A.G.5
Verhoef, J.C.6
Junginger, H.E.7
-
20
-
-
0028341109
-
Bioadhesive polymers for the peroral delivery of peptide drugs
-
Lueßen, H.L., Lehr C.-M., Rentel, C.-O., Noach, A.B.J., de Boer, A.G., Verhoef, J.C. and Junginger, H.E., Bioadhesive polymers for the peroral delivery of peptide drugs. J. Controlled Rel., 29 (1994) 329-338.
-
(1994)
J. Controlled Rel.
, vol.29
, pp. 329-338
-
-
Lueßen, H.L.1
Lehr, C.-M.2
Rentel, C.-O.3
Noach, A.B.J.4
De Boer, A.G.5
Verhoef, J.C.6
Junginger, H.E.7
-
21
-
-
85030271301
-
Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro
-
in press
-
Lueßen, H.L., Rentel, C.-O., Kotzé, A., Lehr, C.-M., de Boer, A.G., Verhoef, J.C. and Junginger, H.E., Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. J. Controlled Rel., (in press).
-
J. Controlled Rel.
-
-
Lueßen, H.L.1
Rentel, C.-O.2
Kotzé, A.3
Lehr, C.-M.4
De Boer, A.G.5
Verhoef, J.C.6
Junginger, H.E.7
-
22
-
-
0026446209
-
Mucus models for investigation of intestinal absorption. Part 2: Mechanisms of drug interaction with intestinal mucus
-
Matthes, I., Nimmerfall, F. and Sucker, H., Mucus models for investigation of intestinal absorption. Part 2: Mechanisms of drug interaction with intestinal mucus. Pharmazie, 47 (1992) 609-613.
-
(1992)
Pharmazie
, vol.47
, pp. 609-613
-
-
Matthes, I.1
Nimmerfall, F.2
Sucker, H.3
-
23
-
-
0026789983
-
Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats
-
Morishita, I., Morishita, M., Takayama, K., Machida, Y. and Nagai, T., Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int. J. Pharm., 78 (1992) 9-16.
-
(1992)
Int. J. Pharm.
, vol.78
, pp. 9-16
-
-
Morishita, I.1
Morishita, M.2
Takayama, K.3
Machida, Y.4
Nagai, T.5
-
24
-
-
3843114537
-
The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools
-
in press
-
Rubinstein, A., Tirosh, B., Baluom, M., Nassar, T., David, A., Radai, R., Gliko-Kabir, I. and Friedmann, M., The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. J. Controlled Rel., (1996) in press.
-
(1996)
J. Controlled Rel.
-
-
Rubinstein, A.1
Tirosh, B.2
Baluom, M.3
Nassar, T.4
David, A.5
Radai, R.6
Gliko-Kabir, I.7
Friedmann, M.8
-
25
-
-
0023728781
-
Vasopressin: A model for the study of effects of additives on the oral and rectal administration of peptide drugs
-
Saffran, M., Breda, C., Kumar, G.S. and Neckers, D.C., Vasopressin: a model for the study of effects of additives on the oral and rectal administration of peptide drugs. J. Pharm. Sci., 77 (1988) 33-38.
-
(1988)
J. Pharm. Sci.
, vol.77
, pp. 33-38
-
-
Saffran, M.1
Breda, C.2
Kumar, G.S.3
Neckers, D.C.4
-
26
-
-
0011783293
-
Physiologische und pharmakologische wirkungen von buserelin: Präklinische untersuchungen
-
Schindler, A.E. and Schweppe K.W. (Eds.), Walter de Gryter, Berlin
-
Sandow, J., Physiologische und pharmakologische Wirkungen von Buserelin: präklinische Untersuchungen. In Schindler, A.E. and Schweppe K.W. (Eds.), Endometriose-Neue Therapiemöglichkeiten durch Buserelin. Walter de Gryter, Berlin, 1989, pp. 23-42.
-
(1989)
Endometriose-Neue Therapiemöglichkeiten Durch Buserelin
, pp. 23-42
-
-
Sandow, J.1
-
27
-
-
0025825296
-
Degradation of insulin by trypsin and α-chymotrypsin
-
Schilling, R.J. and Mitra, A., Degradation of insulin by trypsin and α-chymotrypsin. Pharm. Res., 8 (1991) 721-727.
-
(1991)
Pharm. Res.
, vol.8
, pp. 721-727
-
-
Schilling, R.J.1
Mitra, A.2
-
28
-
-
0026584008
-
Autophagy and other vacuolar protein degradation mechanisms
-
Seglen, P.O. and Bohley, P., Autophagy and other vacuolar protein degradation mechanisms. Experientia, 48 (1992) 158-171.
-
(1992)
Experientia
, vol.48
, pp. 158-171
-
-
Seglen, P.O.1
Bohley, P.2
-
30
-
-
0014489855
-
Pyrrolidonyl peptidase in bacteria. The enzyme from Bacillus subtillis
-
Szewczuk, A. and Mulczyk, M., Pyrrolidonyl peptidase in bacteria. The enzyme from Bacillus subtillis. Eur. J. Biochem., 8 (1969) 63-67.
-
(1969)
Eur. J. Biochem.
, vol.8
, pp. 63-67
-
-
Szewczuk, A.1
Mulczyk, M.2
-
31
-
-
0001062110
-
Faster, shorter and more profound action of Lys (B28) Pro (B29) human insulin analogue compared to regular insulin irrespective of the injection site
-
Ter Braak, E.W.T.M., Bianci, R. and Erkelens, D.W., Faster, shorter and more profound action of Lys (B28) Pro (B29) human insulin analogue compared to regular insulin irrespective of the injection site. Diabetes, 42 (1993) 207A.
-
(1993)
Diabetes
, vol.42
-
-
Ter Braak, E.W.T.M.1
Bianci, R.2
Erkelens, D.W.3
-
33
-
-
0028239031
-
Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs
-
Zhou, X.H., Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. J. Controlled Rel., 29 (1994) 239-252.
-
(1994)
J. Controlled Rel.
, vol.29
, pp. 239-252
-
-
Zhou, X.H.1
|